Robert Wilson is listed as a director on 5 SEC Form D filings by 1 issuer between Feb 2021 and Oct 2026: InSitu Biologics, Inc. (Oakdale, MN — biotechnology — 2021–2026; $4.97M reported sold to 29 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Bill Taylor (5 shared filings), Daniel Halpern (3 shared filings), Greg Van Guilder (3 shared filings), Ivan Shaw (3 shared filings), Sandi Klemann (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 SEC releases, 2 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Robert Wilson and found 10 differences, 1 worth asking the sponsor about: Form D filed 241 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.